Therapeutic response to ramucirumab + folfiri in patients with metastatic gastric cancer

BACKGROUND: Gastric tumors are important gastrointestinal malignancies, and the prediction of therapeutic responses and related factors are important to improve the prognosis. Hence the aim of this study was to determine the therapeutic response to ramucirumab + folfiri in patients with metastatic g...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezvani, Hamid, Haghighi, Shirin, Ghobakhlou, Mehdi, Ataei, Elnaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731017/
https://www.ncbi.nlm.nih.gov/pubmed/36505597
http://dx.doi.org/10.4103/jfmpc.jfmpc_1678_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731017/
https://www.ncbi.nlm.nih.gov/pubmed/36505597
http://dx.doi.org/10.4103/jfmpc.jfmpc_1678_21

Ejemplares similares